Send Enquiry

PRIMA
Tablets
Packaging and packing Type
Blister | 10x10
MRP :
₹415
PTR :
₹316.19
PTS :
₹284.57
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Gynae PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Vibnemic MF is a tablet that carries Tranexamic Acid 500 mg and Mefenamic Acid 250 mg in a single dosage form. It sits in the gynaecology and women's health class and is packed as 10x10 (Blister). Vibnemic MF comes from Vibcare Pharma's Prima division.
Tranexamic acid is an antifibrinolytic: it keeps the fibrin in a blood clot from being dissolved, so menstrual bleeding is brought down. Mefenamic acid is a non-steroidal anti-inflammatory drug that blocks prostaglandin production in the tissues and eases cramps around menstruation. The two act on bleeding and on pain at the same time.
Vibnemic MF is used for cyclic heavy menstrual bleeding, primary dysmenorrhoea and short-term mild to moderate pain. Mefenamic acid can raise the risk of heart attack or stroke and of stomach or intestinal bleeding, ulceration or perforation; seek urgent medical care for chest pain, one-sided weakness, black stools or vomiting blood.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Vibnemic MF Tablet is part of Vibcare Pharma's gynae range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Vibnemic MF tablets with Tranexamic Acid 500 mg and Mefenamic Acid 250 mg for heavy menstrual bleeding and period pain. Main uses: treatment of cyclic heavy menstrual bleeding in women of reproductive potential; relief of primary dysmenorrhoea (painful periods); short-term relief of mild to moderate pain when therapy does not exceed one week.
Common side effects of Vibnemic MF Tablet include headache; abdominal pain; back pain and muscle cramps; nausea, indigestion or diarrhoea; dizziness; sinus and nasal symptoms. Get medical help at once if you notice venous or arterial thrombosis or thromboembolism, including retinal artery or vein occlusion; gastrointestinal bleeding, ulceration or perforation; severe allergic reaction or serious skin reactions.
Each Vibnemic MF tablet contains Tranexamic Acid 500 mg + Mefenamic Acid 250 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Vibnemic MF Tablet only as your doctor advises.
The MRP of Vibnemic MF Tablet is ₹415 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹316.19 and the PTS is ₹284.57.
Each Vibnemic MF tablet contains Tranexamic Acid 500 mg + Mefenamic Acid 250 mg. It comes in a pack of 10x10 (Blister).
Tranexamic acid is an antifibrinolytic: it keeps the fibrin in a blood clot from being dissolved, so menstrual bleeding is brought down. Mefenamic acid is a non-steroidal anti-inflammatory drug that blocks prostaglandin production in the tissues and eases cramps around menstruation. The two act on bleeding and on pain at the same time.
Must not be used by women taking combined hormonal contraceptives. Must not be used in active thromboembolic disease, a history of thrombosis or thromboembolism, or an intrinsic risk of thrombosis (including retinal vein or artery occlusion). Must not be used by anyone allergic to tranexamic acid or mefenamic acid. Must not be used by patients who have had asthma, urticaria or allergic-type reactions after aspirin or other NSAIDs. Must not be used in the setting of coronary artery bypass graft surgery.
Vibnemic MF Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner